Exciting news! 🎉 We're thrilled to announce the launch of our new online ordering platform. Now, you can easily browse, select, and order LuxSit™ Pro products directly from our website. Visit us here: https://lnkd.in/gaTNm_E9 🌐
Monod Bio
Biotechnology Research
Seattle, Washington 2,442 followers
Simple and powerful biosensors for medicine and biotechnology.
About us
Monod Bio is a pioneer company in the design of de novo protein biosensors. Our innovative biosensor platform technology takes advantage of the most recent advances in computational protein engineering to create highly modular biosensing nanoswitches that enable rapid, sensitive, and inexpensive analytical assays. Our visionary founding team and state-of-the-art technology position Monod Bio at the forefront of biosensor innovation, and we welcome exceptional individuals to join us in this journey.
- Website
-
https://www.monod.bio/
External link for Monod Bio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Seattle, Washington
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
4000 Mason Rd
Seattle, Washington 98195, US
Employees at Monod Bio
Updates
-
🎉 It's Here! 🎉 We are excited to announce the release of our first product, LuxSit™ Pro, the world's first fully de novo luciferase and for the first fully de novo protein to reach the commercial market. LuxSit™ Pro is small, hyperstable, and available in both full length and split formats. Have a look at today's press release: https://lnkd.in/gA-8RKWp and visit us here to order LuxSit™ Pro: https://lnkd.in/ggvUeMMC #productlaunch #denovoprotein #proteindesign #monodbio #LuxSitPro #luciferase
-
🎉 It's Here! 🎉 We are excited to announce the release of our first product, LuxSit™ Pro, the world's first fully de novo luciferase and for the first fully de novo protein to reach the commercial market. LuxSit™ Pro is small, hyperstable, and available in both full length and split formats. Have a look at today's press release: https://lnkd.in/gA-8RKWp and visit us here to order LuxSit™ Pro: https://lnkd.in/ggvUeMMC #productlaunch #denovoprotein #proteindesign #monodbio #LuxSitPro #luciferase
Monod Bio Launches World's First Fully De Novo Protein Product: Luciferase LuxSit™ Pro for Life Sciences Research and Diagnostics
prnewswire.com
-
Happy 4th of July! 🌟 At Monod Bio, we're wishing everyone a safe and joyful holiday filled with celebration and reflection. Happy Independence Day! #IndependenceDay #4thOfJuly #Celebrate #MonodBio
-
We're thrilled to be part of hosting the OUTbio Seattle Pride Party at Dexter Yard tomorrow! Join us for stunning rooftop views along with delicious food & beverages. Happy Pride! 🌈 #SeattlePride #biotech #PrideMonth
-
Congratulations to Élyse Fischer!🚴♀️ We're thrilled to announce that Élyse Fischer has won BioMed Realty's annual May Bike Month Challenge here at Dexter Yard... for the second year in a row! 🎉 We're incredibly proud to see our talented staff being recognized outside of the lab. Keep pedaling, Élyse! #BikeMonth #BMRChallenge #CyclingChampion #GoElyse
-
We are delighted to announce that our advisor, Gonçalo Bernardes, PhD, has been honored with the 2024 Corday-Morgan Mid-Career Prize for Chemistry by the Royal Society of Chemistry. This prestigious award highlights Dr. Bernardes' dedication and groundbreaking work in targeted therapeutics, including small molecule-based RNA degradation, at the University of Cambridge. Congratulations, Dr. Bernardes, on this well-deserved recognition! Link: https://lnkd.in/ejxRWH-u
Professor Gonçalo Bernardes - 2024 Corday-Morgan Mid-Career Prizes for Chemistry winner
rsc.org
-
At #BIO2024, our CEO and Co-Founder, Daniel-Adriano S., PhD, spoke at the AI's Impact on Oncology Cancer Drug Development panel along with other CEOs. During the panel, he discussed the relevance of our technology to the development of companion diagnostics. Additionally, he and the other panelists discussed AI's impact in the next 2, 5, and 10 years. #artificialintelligence #AI #biotech
-
And that's a wrap to #BIO2024! We were thrilled to see that BIO 2024 was bustling, well-attended, and very productive. This year two of our founders, CEO, Daniel-Adriano S., PhD, and COO, David Shoultz, PhD, MBA, were able to participate. In addition, our Senior Director of Business Development & Commercialization, Matthew Brown, MBA, was in attendance to lead our business development and commercialization efforts. We were pleased to engage in multiple meetings with potential commercial partners and investors, along with the opportunity to meet with select academic partners. #biotech #SanDiego